AC Immune (ACIU) Capital Expenditures Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 16.27% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.09% |
| Sep 30, 2025 | 16.67% |
| Jun 30, 2025 | 6.86% |
| Mar 31, 2025 | 11.69% |
| Dec 31, 2024 | -26.43% |
| Sep 30, 2024 | 28.74% |
| Jun 30, 2024 | 52.20% |
| Mar 31, 2024 | 31.14% |
| Dec 31, 2023 | -27.37% |
| Sep 30, 2023 | -5.29% |
| Jun 30, 2023 | 23.77% |
| Mar 31, 2023 | 0.45% |
| Dec 31, 2022 | 40.68% |
| Sep 30, 2022 | -31.43% |
| Jun 30, 2022 | -34.09% |
| Mar 31, 2022 | -4.45% |
| Dec 31, 2021 | 12.12% |
| Sep 30, 2021 | -56.27% |
| Jun 30, 2021 | -18.25% |
| Mar 31, 2021 | 8.34% |
| Dec 31, 2020 | -88.44% |
| Sep 30, 2020 | 94.74% |
| Jun 30, 2020 | 25.38% |
| Mar 31, 2020 | 28.46% |
| Dec 31, 2019 | -60.48% |
| Sep 30, 2019 | 51.52% |
| Jun 30, 2019 | 149.74% |
| Mar 31, 2019 | -34.38% |
| Dec 31, 2018 | 92.83% |